MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Alpha-synuclein"

  • MDS Virtual Congress 2021

    CHAPERONIC PROPENSITIES OF AFRICAN WALNUT AS A THERAPEUTIC TARGET IN MANGANESE-INDUCED PARKINSON-LIKE NEUROPATHOLOGY IN WISTAR RATS

    O. Tokunbo, B. Enaibe, T. Abayomi (Osogbo, Nigeria)

    Objective: Herein, the chaperonic propensities of ethanolic extract of African walnut (WNE) in Manganese-induced Parkinson-like neuropathology in the prefrontal cortex and hippocampus was investigated. Background:…
  • MDS Virtual Congress 2021

    Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson’s disease

    E. Cinar, G. Yalcin-Cakmakli, A. Ulusoy, E. Saka, B. Tel, B. Elibol (Zonguldak, Turkey)

    Objective: To examine the possible neurorestorative effects of chronic rapamycin treatment in AAV-mediated alpha-synuclein (a-syn) overexpression model of Parkinson’s disease (PD), designed to induce hippocampal…
  • MDS Virtual Congress 2021

    An Unusual Case of Multiple Systems Atrophy with Long Disease Duration, Severe Gliosis, and Scant Synuclein Pathology

    D. Coughlin, I. Dryden, B. Wright, S. Lessig, D. Galasko, A. Hiniker (San Diego, USA)

    Objective: To describe a pathologically unusual case of Multiple systems atrophy (MSA) with severe widespread gliosis and neuronal loss with scant alpha-synuclein (aSyn) pathology. Background:…
  • MDS Virtual Congress 2021

    Double labeling alpha-synuclein in labial minor salivary glands in Parkinson’s disease and idiopathic RBD patients

    G. Mangone, M. Houot, S. Boluda Casas, A. Chalancon, A. Prigent, D. Seilhean, JC. Corvol, M. Vidailhet, C. Duyckaerts, B. Degos (Paris, France)

    Objective: To investigate the presence of α-Syn immunostaining in minor salivary gland biopsies (MSGB) from patients with idiopathic Parkinson's disease (PD), idiopathic Rapid Eye Movement…
  • MDS Virtual Congress 2021

    Mapping regional alpha-synuclein seeding capacity in Multiple System Atrophy

    I. Martinez-Valbuena, N. P. Visanji, A. Kim, S. Lee, S. Alshimemeri, R. So, A. Gao, J. C. Watts, A. Lang, G. G. Kovacs (Toronto, Canada)

    Objective: The objective of our work was to develop a novel high-throughput cell-free assay that allowed us to perform a comprehensive characterization of α-synuclein seeding…
  • MDS Virtual Congress 2021

    Lipid metabolism alterations in the lysosomal membrane promotes chaperone-mediated autophagy dysfunction and alpha-synuclein pathology in Parkinson’s disease associated to GBA

    A. Navarro-Romero, I. Fernandez-Gonzalez, M. Montpeyo, J. Riera, E. Pradas, JA. Arranz, C. Carnicer-Caceres, M. Martinez-Vicente (Barcelona, Spain)

    Objective: The objective of this study was to generate and characterize a new in vitro neuronal model of Parkinson's diseases associated to GBA (PD-GBA) that…
  • MDS Virtual Congress 2021

    Natural History of Probable MSA in India: A Prospective Cohort Study

    MR. Rukmani, R. Yadav, B. Bhaskarapillai, PK. Pal, TN. Sathyaprabha (Bangalore, India)

    Objective: We aimed to prospectively study the natural history of probable multiple system atrophy (MSA) including autonomic testing, survival analysis; and assess whether serum alpha-synuclein…
  • MDS Virtual Congress 2021

    Biofluid Biomarkers in Prodromal Parkinson’s Disease

    B. Mollenhauer, L. Chahine, M. Dakna, M. Bartl, A. Siderowf, SJ. Hutten, K. Merchant, K. Marek, D. Galasko (Kassel, Germany)

    Objective: To analyze biomarker signatures in biofluids in prodromal Parkinson’s disease (PD) to identify subjects at-risk to conversion and for progression. Background: Individuals at-risk for…
  • MDS Virtual Congress 2021

    Oligodendroglial-derived exosomes as mediators of α-synuclein pathology in MSA-like models

    M. Vetsi, G. Tsaka, P. Mavroeidi, F. Arvanitaki, M. Zweckstetter, S. Becker, PH. Jensen, L. Stefanis, M. Xilouri (Athens, Greece)

    Objective: The current study focuses in elucidating the contribution of oligodendroglial-derived exosomes in the development and spread of α-Synuclein (αSyn) pathology in Multiple System Atrophy…
  • MDS Virtual Congress 2021

    Neurofilament light chain serum levels in E46K-SNCA mutation carriers

    A. Murueta-Goyena, MA. Acera, N. Ayo, M. Carmona-Abellán, R. Del Pino, I. Gabilondo, B. Tijero, T. Fernandez, M. Ruiz, JC. Gómez-Esteban, E. Capetillo, R. Cipriani, F. Zallo, F. Cavaliere (Barakaldo, Spain)

    Objective: To demonstrate the usefulness of measuring the concentration of neurofilament light chain (NfL) in blood using Single Molecule Array matrix (SiMoA, Quanterix) as a…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley